Your browser doesn't support javascript.
loading
treatment of masseter hypertrophy with botulinum toxin type A
Saudi Medical Journal. 2006; 27 (3): 397-400
in English | IMEMR | ID: emr-80732
ABSTRACT
Masseter hypertrophy is a benign condition with variable causative factors, such as bruxism, temporomandibular disorders, malocclusion and others, but has an unclear etiology in the majority of cases. Surgical masseteric resection was the conventional method of treatment for the asymmetric swellings over the ramus and angle of the mandible on one or both sides, in addition to the generally unsuccessful treatments of occlusal adjustment, splint therapy, tranquilizers or others. An effective alternative was the local injection of very small doses of botulinum toxin type A into the masseter. The toxin binds permanently to the motor end plate preventing acetylcholine release causing pre-synaptic neuromuscular blockade, the muscle can be selectively weakened and local paralysis is followed by atrophy of the muscle. Four cases with their follow-up are reported. This technique provided a predictable and conservative method of treatment for this type of facial asymmetry
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Hypertrophy / Injections, Intramuscular / Masseter Muscle Type of study: Case report Limits: Female / Humans / Male Language: English Journal: Saudi Med. J. Year: 2006

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Hypertrophy / Injections, Intramuscular / Masseter Muscle Type of study: Case report Limits: Female / Humans / Male Language: English Journal: Saudi Med. J. Year: 2006